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ACC White Papers
n Avenue for Interventional Knowledge?
eorge D. Dangas, MD, Jeffrey J. Popma, MD, on behalf of the
CC Interventional Scientific CouncilM
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on the last few months, Anthony N. DeMaria,
D, Editor-in-Chief of the Journal of the Ameri-
an College of Cardiology (JACC) has been commis-
ioning articles for a new department known as
JACC White Papers.” Spencer B. King III, MD,
ditor-in-Chief of JACC: Cardiovascular Interven-
ions, plans to launch a similar feature in his journal
oon. The White Papers, which will be published
n a periodic basis, offer the opportunity for
nterventional cardiologists to tap their profes-
ional experience and wisdom and provide guid-
nce to the cardiology community on a variety of
mportant topics. It has been an ongoing initiative
f the year-old ACC Interventional Scientific
ouncil and Section to push for the development
f outlets such as this so that interventionalists can
rovide their professional experiences as a platform
or continued learning and progress within this
ubspecialty. It is the hope of the Section that these
hite Papers will act as a catalyst for progressive
nowledge-sharing and as a guide for future
ecision-making within the subspecialty and the
ollege. Below, Drs. DeMaria and King offer
nsight into the plan and goals for the White Paper
nitiative.
The rationale behind the creation of the White
aper initiative is to address the number of com-
only encountered clinical issues that exist with-
ut definitive data to support and guide decision
aking. While many of these issues are not large
nough to grow into a formal guideline document,
hey are significant enough to warrant addressing.
ccording to Dr. DeMaria, these White Papers
ould allow recognized experts and authorities to
ummarize the data that do exist, and then offer
heir perspective on the current best course of
ction.
There are many topics considered suitable for a
hite Paper submission. For example, Dr. De-
aria suggested one appropriate topic would be to
iscuss the best risk-management strategy behind
iving patients multiple anticoagulant-type drugs. tany patients require multiple drugs after treat-
ent. For example, aspirin and clopidogrel are
eeded after a coronary stenting procedure, and
oumadin can be added when atrial fibrillation or
prosthetic heart valve is involved. When giving
atients all 3 of these drugs, there is a significant
ncrease in bleeding risk. “A White Paper discuss-
ng the best course of action given the data we
ave, would be a relevant and timely topic,” said
r. DeMaria. Another example would be the best
pproach for treating bifurcation lesions, since that
s an area where there are no definitive data.
ccording to Dr. DeMaria, this topic is in fact a
it of a “moving target,” because new approaches
re being constantly developed.
It is the hope of Drs. DeMaria and King that
hese White Papers will serve to inform the clinical
ardiovascular community as well as serve 2 addi-
ional purposes: to point out areas where data are
eeded, so that the appropriate randomized trials
an be performed; and to act as a stimulus to
uideline writing committees once the data are
vailable. They stress, however, that the White
aper initiative is not a way to circumvent the
urrent guideline processes.
“It is important to say that we are not trying to
kirt the guideline process. We are trying to sup-
lement it with focused recommendations from a
roup of respected authorities in areas where there
eally is no consensus,” says Dr. DeMaria.
Dr. King also sees these White Papers as an
pportunity to advocate updates in guidelines al-
eady in place. “By the time guidelines come out,
ometimes from the perspective of the interven-
ional community, there are things we think may
arrant a change,” says Dr. King. “A White Paper
ould make the case for updates in guidelines. But
here is a line between an op-ed piece and a White
aper. A White Paper would reflect the considered
pinion from a group.”
By accomplishing the aforementioned purposes,he White Papers also give representatives of the
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473nterventional community a stronger voice in shaping the
onversation around important clinical issues, allowing
hem an opportunity to state their opinion, taking into
ccount not only the data but also their judgment and
xperience. Dr. King also sees the initiative as an opportu-
ity to hear voices within the community that might
therwise be silenced by the majority.
“I think it allows for some democratization of the process
nd more openness. One thing you struggle with in writing
uidelines is the need to avoid a minority report, so you
ork for consensus as hard as you can, and you get it. But
t does not always mean that that is all the opinions there
re,” says Dr. King. “When there are issues that have not
een addressed, or alternative opinions, or serious questions
bout practice performance—how to do something—there
hould be a mechanism whereby people can get together and
ropose a paper on that subject.”
This openness and collaboration is what makes this
nitiative a supporting player in the College’s Quality First
hilosophy, and according to Dr. DeMaria, is one of the
easons for the implementation of the White Papers.
When uncertainty exists, usually there is not a complete
bsence of information or agreement,” says Dr. DeMaria.
So White Papers will say, ‘While it is true that there are no
efinitive data of the various options that are available, the
ulk of information would suggest one of the approaches is
etter than the others.’ We hope that will lead to higher-
uality practice.”
If a topic has broad interest, Drs. DeMaria and King
ope to have the White Paper published in JACC and then
oint individuals to JACC: Cardiovascular Interventions.
sowever, more focused topics will likely be published solely
n Interventions due to their specialized character.
“An example [of a more specialized topic] might be
echnical aspects of aortic valve implantation, or how to
tructure a training program in structural heart disease,”
ays Dr. King. “I expect many ideas for White Papers will
ubble up from the Section and Council on Interventional
ardiology.”
The White Papers should ultimately make expert guid-
nce available to the cardiology community more quickly;
owever, Dr. DeMaria notes that the timeline is dependent
n the time it takes to review.
“We hope we can get the White Papers to press in a
ouple of months. These manuscripts do have to undergo
eer review, so it will depend on the review process,” says
r. DeMaria.
The ACC Interventional Scientific Council and Section
rges all interventional cardiologists to take an active part in
his knowledge-sharing initiative and the future of the inter-
entional subspecialty by participating in the White Paper
iscussion and submitting White Papers on topics of interest.
Interventionalists can work to influence the subspecialty
ith initiatives such as this, as well as issues across the
readth of cardiology by joining the member section. Visit
ttp://www.cardiosource.com/cvn/index.asp?channelid27
o learn more and discover the new initiatives the Section is
orking on during 2009.
eprint requests and correspondence: ACC Interventional Sci-
ntific Council, phone 202-375-6649, fax 202-375-6842, E-mail:
bailes@acc.org.
